GR3015461T3 - 7-Keto- and 7-Hydroxy-androsta-3,5-diene-3-carboxylic acid derivatives. - Google Patents
7-Keto- and 7-Hydroxy-androsta-3,5-diene-3-carboxylic acid derivatives.Info
- Publication number
- GR3015461T3 GR3015461T3 GR950400592T GR950400592T GR3015461T3 GR 3015461 T3 GR3015461 T3 GR 3015461T3 GR 950400592 T GR950400592 T GR 950400592T GR 950400592 T GR950400592 T GR 950400592T GR 3015461 T3 GR3015461 T3 GR 3015461T3
- Authority
- GR
- Greece
- Prior art keywords
- keto
- alpha
- androsta
- diene
- hydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
- C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
- C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/398,192 US5032586A (en) | 1989-08-24 | 1989-08-24 | 7-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5-alpha reductase |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3015461T3 true GR3015461T3 (en) | 1995-06-30 |
Family
ID=23574362
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR950400592T GR3015461T3 (en) | 1989-08-24 | 1995-03-20 | 7-Keto- and 7-Hydroxy-androsta-3,5-diene-3-carboxylic acid derivatives. |
Country Status (15)
Country | Link |
---|---|
US (1) | US5032586A (el) |
EP (1) | EP0414529B1 (el) |
JP (1) | JPH03118326A (el) |
KR (1) | KR910004653A (el) |
AT (1) | ATE116657T1 (el) |
AU (1) | AU640396B2 (el) |
CA (1) | CA2023609A1 (el) |
DE (1) | DE69015736T2 (el) |
DK (1) | DK0414529T3 (el) |
ES (1) | ES2066140T3 (el) |
GR (1) | GR3015461T3 (el) |
IE (1) | IE903070A1 (el) |
NZ (1) | NZ235000A (el) |
PT (1) | PT95090A (el) |
ZA (1) | ZA906710B (el) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5516768A (en) * | 1990-03-16 | 1996-05-14 | Smithkline Beecham Corporation | Uncompetitive inhibition of steroid and 5α-reductose |
US5300294A (en) * | 1990-06-27 | 1994-04-05 | Smithkline Beecham Corporation | Method of treating prostatic adenocarcinoma |
IT1259419B (it) * | 1991-05-24 | 1996-03-18 | Erba Carlo Spa | Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi |
IL104601A0 (en) * | 1992-02-07 | 1993-07-08 | Smithkline Beecham Corp | Process for the preparation of steroidal dienes |
US5215894A (en) * | 1992-02-25 | 1993-06-01 | Merck & Co., Inc. | Biological process for producing 17β-N-monosubstituted carbamoyl-11-oxo-4-aza-5-α-androst-3-one testosterone-5-α reductase inhibitors |
ES2105108T3 (es) * | 1992-04-20 | 1997-10-16 | Sankyo Co | Esteroides para el tratamiento de la hipertrofia prostatica, su preparacion y su utilizacion. |
US5710275A (en) * | 1992-05-20 | 1998-01-20 | Merck & Co., Inc. | 7β-substituted-4-aza-5α-androstan-3-ones as 5α-reductase inhibitors |
WO1993023053A1 (en) * | 1992-05-21 | 1993-11-25 | Endorecherche Inc. | INHIBITORS OF TESTOSTERONE 5α-REDUCTASE ACTIVITY |
US5641765A (en) * | 1992-11-18 | 1997-06-24 | Smithkline Beecham Corporation | 17-αand 17-βsubstituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-α-reductase |
US5683995A (en) * | 1992-11-18 | 1997-11-04 | Smithkline Beecham Corporation | 17 substituted acyl-3-carboxy 3,5-diene steroidals as α-reductase inhibitors |
IL107611A0 (en) * | 1992-11-18 | 1994-02-27 | Smithkline Beecham Corp | Steroid compounds and pharmaceutical compositions containing them |
TW369521B (en) * | 1993-09-17 | 1999-09-11 | Smithkline Beecham Corp | Androstenone derivative |
US5637310A (en) * | 1993-12-20 | 1997-06-10 | Smithkline Beecham Corporation | Method of treating prostatic adenocarcinoma |
WO1995028413A1 (en) * | 1994-04-15 | 1995-10-26 | Smithkline Beecham Corporation | 17β-SUBSTITUTED 3-CARBOXY STEROIDS THAT INHIBIT 5-α-REDUCTASE |
AU3826095A (en) * | 1994-10-05 | 1996-05-02 | Smithkline Beecham Corporation | Process for preparing 17-beta-substituted-androsta-3,5-dien-3-carboxylic acids |
US5541322A (en) * | 1994-10-14 | 1996-07-30 | Glaxo Wellcome Inc. | Synthesis of 6-azaandrostenones |
US5887683A (en) * | 1996-12-23 | 1999-03-30 | Shimano Inc. | Brake adjusting device |
WO1999061055A1 (en) | 1998-05-22 | 1999-12-02 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules and therapies based thereon |
DK1889198T3 (da) | 2005-04-28 | 2015-02-09 | Proteus Digital Health Inc | Farma-informatiksystem |
JP2009508494A (ja) | 2005-09-16 | 2009-03-05 | ラプトール ファーマシューティカル インコーポレイテッド | Crを含むタンパク質に対して特異的な受容体−結合タンパク質(rap)変異体を含む組成物およびその使用 |
CA2969926C (en) | 2009-02-20 | 2018-05-15 | 2-Bbb Medicines B.V. | Glutathione-based drug delivery system |
IL295075A (en) | 2009-05-06 | 2022-09-01 | Laboratory Skin Care Inc | Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4377584A (en) * | 1978-04-13 | 1983-03-22 | Merck & Co., Inc. | 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors |
US4191759A (en) * | 1978-04-13 | 1980-03-04 | Merck & Co., Inc. | N-substituted-17β-carbamoylandrost-4-en-3-one 5α reductase inhibitors |
US4317817A (en) * | 1979-08-27 | 1982-03-02 | Richardson-Merrell Inc. | Novel steroid 5α-reductase inhibitors |
DK465481A (da) * | 1980-11-21 | 1982-05-22 | Hoffmann La Roche | Fremgangsmaade til fremstilling af d-homostemoider |
US4814324A (en) * | 1987-03-06 | 1989-03-21 | Merck & Co., Inc. | Sterol inhibitors of testosterone 5α-reductase |
US4910226A (en) * | 1987-04-29 | 1990-03-20 | Smithkline Beckman Corporation | Steroid 5-alpha-reductase inhibitors |
-
1989
- 1989-08-24 US US07/398,192 patent/US5032586A/en not_active Expired - Fee Related
-
1990
- 1990-08-20 CA CA002023609A patent/CA2023609A1/en not_active Abandoned
- 1990-08-21 NZ NZ235000A patent/NZ235000A/en unknown
- 1990-08-21 AU AU61152/90A patent/AU640396B2/en not_active Ceased
- 1990-08-22 DE DE69015736T patent/DE69015736T2/de not_active Expired - Fee Related
- 1990-08-22 DK DK90309220.3T patent/DK0414529T3/da active
- 1990-08-22 AT AT90309220T patent/ATE116657T1/de not_active IP Right Cessation
- 1990-08-22 ES ES90309220T patent/ES2066140T3/es not_active Expired - Lifetime
- 1990-08-22 EP EP90309220A patent/EP0414529B1/en not_active Expired - Lifetime
- 1990-08-23 ZA ZA906710A patent/ZA906710B/xx unknown
- 1990-08-23 PT PT95090A patent/PT95090A/pt not_active Application Discontinuation
- 1990-08-23 IE IE307090A patent/IE903070A1/en unknown
- 1990-08-23 JP JP2224148A patent/JPH03118326A/ja active Pending
- 1990-08-24 KR KR1019900013108A patent/KR910004653A/ko not_active Application Discontinuation
-
1995
- 1995-03-20 GR GR950400592T patent/GR3015461T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
PT95090A (pt) | 1991-04-18 |
NZ235000A (en) | 1992-03-26 |
IE903070A1 (en) | 1991-02-27 |
DE69015736T2 (de) | 1995-05-11 |
CA2023609A1 (en) | 1991-02-25 |
DK0414529T3 (da) | 1995-05-22 |
EP0414529A2 (en) | 1991-02-27 |
ES2066140T3 (es) | 1995-03-01 |
ATE116657T1 (de) | 1995-01-15 |
AU6115290A (en) | 1991-02-28 |
EP0414529B1 (en) | 1995-01-04 |
KR910004653A (ko) | 1991-03-29 |
DE69015736D1 (de) | 1995-02-16 |
US5032586A (en) | 1991-07-16 |
ZA906710B (en) | 1991-09-25 |
AU640396B2 (en) | 1993-08-26 |
EP0414529A3 (en) | 1991-07-24 |
JPH03118326A (ja) | 1991-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3015461T3 (en) | 7-Keto- and 7-Hydroxy-androsta-3,5-diene-3-carboxylic acid derivatives. | |
GR3004902T3 (el) | ||
HU9401415D0 (en) | Enzofuranyl- and -thiophenyl-alkane-carboxylic acid derivatives, pharmaceutical compositions contaning them, and process for producing them | |
ES8703881A1 (es) | Procedimiento para la fabricacion de derivados del acido &- (oxo-2 hexahidro-2,4,5,6,7,7a tieno (3,2-c)piridil-5) fenil acetico | |
ES8800272A1 (es) | Un procedimiento para la preparacion de polipeptidos. | |
IE883391L (en) | Novel compounds | |
IL91941A0 (en) | Preparation of 7-substituted-hept-6-enoic and-heptanoic acids and derivatives and intermediates thereof | |
MY117090A (en) | Substituted benzamidines, their preparation and their use as pharmaceutical compounds | |
ES2064661T3 (es) | 11-ceto o hidroxi-3,5-dieno-esteroides como inhibidores de esteroide-5-alfa-reductasa. | |
ES8703460A1 (es) | Un procedimiento para preparar aminoacil-ladanos | |
EP0228845A3 (en) | N-containing heterocyclic compounds, processes for the preparation thereof and composition comprising the same | |
HUT47844A (en) | Process for producing pharmaceuticals comprising quinoline- or naphthyridinecarboxylic acid and tetracyclin derivatives as active ingredient | |
ES8504682A1 (es) | Un procedimiento para la preparacion de compuestos nitro alifaticos | |
ES8607218A1 (es) | Un procedimiento para preparar compuestos de amidina | |
ES8700242A1 (es) | Un procedimiento para preparar un derivado de dihidropirida-zinona | |
ES8104222A1 (es) | Un procedimiento para la preparacion de derivados del acido 7-oxo-1-aza-biciclo (3,2,0) hept-2-en-2-carboxilico | |
DE3374005D1 (en) | 1-methyl-5-nitro-imidazoline derivatives and therapeutic compositions which contain them as active principle | |
AU640161B2 (en) | 3-substituted nitro-steroid derivatives as 5-alpha-reductase inhibitors | |
MY110751A (en) | Positive inotropic and lusitropic pyrroloquinolinone derivatives | |
EG20562A (en) | Process for preparing glutaramide derivatives | |
ES8308562A1 (es) | Procedimiento para preparar 3',4',5'-trimetoxibenzoato de 1718-dehidorapovincaminol, util como agente activo en preparaciones farmaceuticas | |
IL85229A0 (en) | Novel imidazo-and triazolothiadiazines,a process for the preparation thereof,pharmaceutical compositions containing same,and the use thereof | |
ES8706663A1 (es) | Procedimiento para la obtencion de 2-tiocromenilidenacetoacetatos | |
JPS5711975A (en) | Aminophenyltetrazole derivative and salt thereof | |
GEP19971045B (en) | Method for production of derivatives of acrylic acid and its stereoisomers |